Executive & Scientific

Image of Heather

Heather King

Chief Executive Officer

Heather has over 30 years’ experience in the life sciences sector, leading and working with boards. She is Entrepreneur in Residence at the Institute of Cancer Research and holds an MBA from Durham University, along with a physiology degree.

Heather has extensive experience leading boards and senior management teams in therapeutic and medical device companies. Her background includes working in a number of university spinout companies and she has also been part of the leadership team in several UK listed biotechnology companies. With an initial background in clinical research, Heather has led a number of drug development programmes and has also held roles in large pharmaceutical companies and international contract research organisations. She has also worked with a selection of companies, ranging from small private UK businesses to large global players, to help devise and implement their strategy. As a mentor for both academic and student company founders, and Entrepreneur in residence at the Institute of Cancer Research, she is passionate about translating science and technology into commercial products to improve patients’ lives. She is also committed to supporting the development and growth of female founders in the STEM arena.

Ann Savell

Chief Operational Officer

Ann has had over 20 years’ experience within clinical, regulatory and quality within the NHS and private sector. Her roles have included Director of Operations at OrthoMimetics Ltd, Associate Director of Clinical Operations and Study Management at Prosidion Ltd, and positions at Wyeth UK, GlaxoSmithKline and Associate Director at PPD, a leading global CRO. Ann also spent 4 years at Leo Pharmaceuticals where she completed her MBA with the Open University.

Ann graduated as a State Registered Nurse in 1982 and entered the pharmaceutical industry 3 years later where she began her career as a Clinical Research Associate with Innovex, a highly regarded Contract Research Organisation. Ann has had a career that has spanned both NHS and industry, and she has held roles in teaching, development and management.

Dr Jennifer Rohn

Chief Scientific Officer

Jenny is the Head of the Centre for Urological Biology in the Division of Medicine at University College London, based at the Royal Free Hospital. She has a PhD in Microbiology from the University of Washington in Seattle, USA, and has been involved in cell, molecular and microbiological research in both academic and biotech settings in several different countries since 1989. She joined UCL in 2007, and has been involved with AtoCap since its inceptions, guiding CapFuran® through all preclinical lab testing from prototype to final formulation.

Her particular expertise and interest is in the molecular interactions of pathogens with the human cells they infect, and she has a keen interest in blending basic science with translational research goals in an interdisciplinary, multi-collaborative and clinical setting.